The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable to military hardening and integration with communication capabilities to support the medical [Read more]
To encourage the development and improvement of Infectious Diseases Next-Generation Sequencing (ID-NGS) analytical methods, precisionFDA – the community platform for NGS assay evaluation and regulatory science exploration – has launched the precisionFDA [Read more]
The U.S. Army is conducting market research to determine the feasibility of a competitive acquisition and to identify potential sources that can provide a Universal Mobile Tester (UMT) for the military’s Joint [Read more]
Illumina, Inc. announced on 15 May that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing (NGS). Edico Genome’s DRAGEN® Bio-IT Platform (DRAGEN) uses field programmable [Read more]
PATH and Mologic have announced a new agreement to work together to advance a rapid diagnostic test to support treatment and elimination of Plasmodium vivax. More than 2.5 billion people worldwide are at risk of [Read more]
The National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS (DAIDS) is seeking proposals from qualified offerors to provide a comprehensive quality assessment program for virologic assays for HIV, and [Read more]
Following the October 2001 confirmation of anthrax in official government mail, a series of screening processes were implemented to safeguard the Pentagon and other Pentagon delegated facilities from biological hazards that might [Read more]
There are only two days left to complete the CFSAN Pathogen Detection Challenge. Sponsored by the U.S. Food and Drug Administration (FDA), Center for Food Safety and Applied Nutrition (CFSAN), the challenge calls on [Read more]
The team that first unveiled the rapid, inexpensive, highly sensitive CRISPR-based diagnostic tool called SHERLOCK has greatly enhanced the tool’s power, and has developed a miniature paper test that allows results to [Read more]
Overt symptoms of many diseases often do not manifest until days after a person’s initial exposure to the causative pathogen, typically a virus or bacteria. By then, the disease may have progressed [Read more]
© 2018 STEMAR MEDIA